COLL 8-K: SEC filing
Collegium Pharmaceutical
Filed with the SEC on · accession 0001628280-26-070585
COLL filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Collegium Pharmaceutical issued a press release and earnings presentation announcing its financial results for the quarterly period ended September 30, 2026.
Key details
✦ Ask GOAX AI about this filing — what it means for COLL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for COLL?
Click hereFrequently asked questions
What did COLL file with the SEC on Nov 5, 2026?
COLL filed a 8-K (SEC filing). Collegium Pharmaceutical issued a press release and earnings presentation announcing its financial results for the quarterly period ended September 30, 2026.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other COLL SEC filings
Get alerts when COLL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days